Tuesday, February 07, 2006 5:24:15 PM
I am not sure what you mean by "DNAPrint is quickly becoming synonmous with genetic biotechnology" inasmuch as any and all the players in this field of technology can be said of the same. The predictive medicine initiatives and possible pharma products are still in very basic research, so your enthusiasm about something big happening soon is unwarranted.
I suggest you simplfy your view of this investment by just confining your consideration to the only factor which, IMHO, is of any importance, and that is the pps. It is the final barometric reading of investor sentiment and the only meaningful criteria of this stock as an investment. Everything else is pumping hot air, smoke and mirrors, as history and, of course, the pps have clearly proven to be true.
JMHO from the actual facts.
dr f
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM